Section one: Contracting authority
one.1) Name and addresses
NHS South Yorkshire Integrated Care Board
197 Eyre Street
Sheffield
S1 3FG
Contact
Procurement
Country
United Kingdom
Region code
UKE32 - Sheffield
Internet address(es)
Main address
https://www.southyorkshire.icb.nhs.uk/
Buyer's address
https://www.southyorkshire.icb.nhs.uk/
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHS SY ICB - Targeted Lung Health Check - Additional Cohorts
two.1.2) Main CPV code
- 85150000 - Medical imaging services
two.1.3) Type of contract
Services
two.1.4) Short description
NHS SY ICB are awarding a contract for the fully managed Mobile Targeted Lung Health Checking service, under the PSR Most Suitable Provider regime.
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £4,000,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKE3 - South Yorkshire
Main site or place of performance
South Yorkshire
two.2.4) Description of the procurement
SY ICB are looking to commission and facilitate Mobile Targeted Lung Health Checks (TLHC) in conjunction with already commissioned service across SY ICB. These services in particular are to enable additional cohorts including but not limited to aged in patients, those moved into the area and initial ‘non-responders’ are given the opportunity to have a lung health check undertaken. This service must be delivered in conjunction with existing services within SY ICB to allow for the best use of resources for SY ICB while ensuring equality of all patients included in the programme both previously and currently.
The purpose of including these additional cohorts is to promote health inequalities and demonstrate SY ICB’s commitment to deliver upon national guidance to ensure all those eligible are receiving health checks. The provider must be able to fit into and extend the current commissioned services to ensure best use of resources by filling current scanner appointments while ensuring additional cohorts as described above are invited to attend in line with these already established locations and processes.
This notice is an intention to award a contract under the most suitable provider process.
This is a new service to be provided by the existing provider.
The contract will run for approx. 4 years form the date of the award of the contract.
two.2.5) Award criteria
Quality criterion - Name: most suitable provider process with regard to the key criteria / Weighting: 100
Cost criterion - Name: Cost / Weighting: 0
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please note, the contract has not been awarded as yet as per section V.1.0.1. This notice is an intention to award a contract under the most suitable provider process. As detailed in II.2.4.1 above.
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the cases listed below
- The procurement falls outside the scope of application of the regulations
Explanation:
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 5th February 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
13 November 2024
five.2.2) Information about tenders
Number of tenders received: 5
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Alliance Medical Ltd
The Woods, Opus 40 Business Park, Warwick
Warwick
CV34 5AH
Country
United Kingdom
NUTS code
- UK - United Kingdom
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Initial estimated total value of the contract/lot: £4,000,000
Total value of the contract/lot: £4,000,000
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on 5th February 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
The contract was approved by the SY ICB Formal Exec Group meeting on 27 November.
No conflicts of interest were declared.
Key criteria 1. Quality and innovation - 30%
AML already have a mobilisation plan for additional cohorts including but not limited to aged in patients, those moved into area, initial 'non-responders' and initial patients whose risk score is likely to have increased since first invitation.
AML also have access to the patient information needed to enable additional cohorts including previous risk scores and 'non-responder' data insights which will inform their contact strategy for increasing uptake by this group, building on their success of increasing overall uptake.
AML have developed effective working relationships with both primary care and secondary care providers across the SYB TLHC footprint. Established and effective communication processes are in place to support and optimise the TLHC pathway which has been co-produced with stakeholders including AML.
AML have information pertaining to the additional needs of our eligible population including Learning Disability, Serious Mental Illness, Visual Impairment and Hearing Impairment, in order that they can personalise their contact strategy and support the SY ICB ambition to further reduce health inequalities.
AML have established partnerships and arrangements with accessible scanning sites across the SYB TLHC footprint which effectively meet the specific needs of our eligible population.
AML have established partnerships and arrangements with accessible scanning sites across the SYB TLHC footprint which effectively meet the specific needs of our eligible population.
Key criteria 2. Value - Weighting 30%
SY ICB have been out to procurement on three separate occasions and AML have been successful each time based on quality and finance. The most recent procurement exercise for Sheffield, Doncaster and Bassetlaw Additional Cohorts commenced February 2024 and concluded with the Contract Award in August 2024. This contract commenced on August 1st 2024.
SY ICB are looking to specifically commission this service to merge with existing resources to reduce the financial and resourcing impact while enabling us to extend the TLHC programme to all who are eligible on a rolling basis. In turn this will ensure SY ICB are able to resource the most cost effective service as possible while ensuring all patients who are eligible are able to access the service.
Transferring data to a new provider also involves additional risk to patients.
Key criteria 3. Integration, collaboration and service sustainability - Weighting 10%
AML have so far achieved 72% coverage for the SYB programme which is the best in the country currently, with future plans to achieve 100% coverage. It is SY ICB’s intention to continue to lead in this area by aiming for 100% which will only be feasible be extending the current provision offered by AML to cover the additional cohorts. Using the current service would improve the sustainability of the new service by allowing operational flexibility, patient flexibility and minimising time and operational costs for the provider to ensure the best value and service for patients.
Key criteria 4. Improving Access, reducing health inequalities and facilitating choice - Weighting 20%
AML have a pre-established process as they also provide TLHC in the areas SY ICB are aiming to target. Access to existing services will be crucial to deliver this activity to the additional cohorts, access to information such as the additional needs of our eligible population including Learning Disability, Serious Mental Illness, Visual Impairment and Hearing Impairment will allow AML and SY ICB to personalise their contact strategy and support the SY ICB ambition to further reduce health inequalities.
Key criteria 5. Social Value - Weighting 10%
AML have selected sites close to the eligible population, tailored to specific PCNs where possible and with good public transport links. This ensures that the patients have good access to the service in an area that suits them based on home or work locations across each Place and Bassetlaw while ensuring changes to national guidance can be adhered to. AML have developed a substantial portfolio of suitable scanning sites (more than 20 to date) to meet the specific needs of our population and based on feedback from local stakeholders who have first hand knowledge of the patient groups they will serve. AML have also sourced alternative sites when required based on data insights and soft intelligence in order to reduce DNAs, increase uptake and enhance patient experience.
six.4) Procedures for review
six.4.1) Review body
NHS South Yorkshire ICB
722 Prince of Wales Road
Sheffield
S9 4EU
Country
United Kingdom